Concert Pharma (CNCE) Sell-off Overdone - Stifel

March 1, 2018 12:26 PM UTC Send to a Friend
Stifel maintains Buy on Concert Pharmaceuticals (NASDAQ: CNCE) price target of $27.00.Analyst Adam Walsh says the sell-off following the shelf ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login